Flavanol-Rich Produce Delivers 27% CVD Mortality Drop in RCT Data: Why Daily Choices Beat Generic Produce Guidelines

The Healthline report correctly flags that most adults fall short of 500 mg daily flavanols, yet it underplays the rigorous evidence hierarchy. COSMOS, a double-blind RCT of 21,442 older adults, demonstrated that 500 mg cocoa flavanols daily reduced cardiovascular death by 27% (HR 0.73) over 3.6 years; this large, industry-supported but pre-registered trial with objective endpoints outweighs the observational EPIC-Norfolk biomarker analysis cited. The new Food & Function modeling, drawing on 30,000 UK/US participants, shows standard NHS or USDA produce targets still yield median intakes below 200 mg, largely because low-flavanol staples dominate. Mars Edge’s lead author Ottaviani correctly notes choice matters, but the piece omits that flavanols act via nitric-oxide-mediated endothelial improvement, a mechanism confirmed in meta-analyses of flow-mediated dilation trials. Practical translation is immediate: swapping one daily apple for blackberries plus green tea routinely exceeds 500 mg without calorie excess. Limitations remain: COSMOS tested supplements, not food matrices, and long-term food-only RCTs are absent. No major conflicts beyond Mars funding were disclosed in primary publications.